PBM as Strategy to CABG Anemic Patients Bypass Graft (CABG)

A phase 2 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 120 participants.

Also called NCT06542393

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 120 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT06542393
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Brazil (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT06542393. Randomized; double masking; primary purpose treatment. Start 2024-06-01 (actual); primary completion 2025-06-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
PBM as Strategy to CABG Anemic Patients Bypass Graft (CABG)
Condition
Anemia
Condition
Coronary Disease
Condition
Coronary Stenosis
Condition
Coronary Occlusion
Condition
Systemic Inflammatory Response
Condition
Bleeding
Condition
Epigenetic Disorder
Intervention (Drug)
Erythropoietin
Intervention (Procedure)
blood transfusion
Lead sponsor
Federal University of São Paulo (class: other)
Collaborator
Fundação de Amparo à Pesquisa do Estado de São Paulo (class: other government)

Record details

Record id
cardio:ct-nct06542393
Content hash
4b58d8f239bb018fc186e090709a641c389ac5faed8c6fdeb77486c5aefc9810